Related by context. All words. (Click for frequent words.) 75 chorea associated 71 Huntexil 69 dimebon 64 vidofludimus 64 Gleevec imatinib mesylate 64 lumiliximab 63 Tasimelteon 63 Lu AA# 63 tetrabenazine 63 methylnaltrexone 63 Aplidin 63 Amrubicin 63 schizophrenia CIAS 62 Plicera 62 Xenazine 62 mGluR2 NAM 62 ProSavin 62 riociguat 62 Pimavanserin 62 SNT MC# 62 cysteamine 62 SPRYCEL ® 62 elotuzumab 62 OHR/AVR# 61 amrubicin 61 BNC# 61 tocilizumab 61 relapsing remitting multiple sclerosis 61 Pirfenidone 61 Nexavar sorafenib 61 neurogenic orthostatic hypotension 61 chorea 61 Targretin 61 HuMax CD4 61 PD LID 61 Archexin 61 Mipomersen 61 Amigal 61 Arcalyst 61 cannabinor 61 tafamidis 61 metaglidasen 61 Vernakalant 61 progressive neurodegenerative disorder 61 EGS# 61 HuLuc# 61 CIMZIA ™ 61 atacicept 60 donepezil Aricept 60 Genz # 60 JAK inhibitor 60 ocrelizumab 60 Gleevec resistant 60 panitumumab Vectibix 60 ISIS # 60 YONDELIS 60 Genentech Rituxan 60 ATryn R 60 aldehyde dehydrogenase ALDH2 deficiency 60 cediranib 60 rufinamide 60 proteasome inhibitor 60 Dapagliflozin 60 rilonacept 60 PRX # 60 multiple myeloma MM 60 Safinamide 60 Phenoptin 60 sitaxsentan 60 Cogane 60 Dasatinib 60 Vilazodone 60 axitinib 60 synthetic retinoid 60 Cinquil 60 lomitapide 60 AA Amyloidosis 60 beta interferon 60 lacosamide 60 lupus nephritis 60 TH# [003] 60 GSK# [001] 60 sJIA 60 beta 1a 60 Behcet uveitis 59 Anavex #-# 59 JAK3 inhibitor 59 Mirapexin 59 Traficet EN 59 gefitinib Iressa 59 davunetide 59 carcinoid syndrome 59 alvespimycin 59 atypical antipsychotic medication 59 calcineurin inhibitor 59 enzastaurin 59 Desmoteplase 59 terlipressin 59 Enzyme Replacement Therapy 59 tiapamil 59 Alzhemed TM 59 CDP# 59 olmesartan 59 Nuvion 59 bardoxolone 59 Vimpat ® 59 Cloretazine R 59 eosinophilic asthma 59 visilizumab 59 TRIOLEX 59 Ambrisentan 59 Catena ® 59 Natalizumab 59 Firazyr 59 Lamotrigine 59 eltrombopag 59 Tarceva erlotinib 59 generation purine nucleoside 59 Tarceva TM 59 HoFH 59 glatiramer acetate 59 haematologic 59 Pemetrexed 59 SRT# [003] 59 ATL# [001] 59 Milnacipran 59 VEGF inhibitors 59 mertansine 59 UPLYSO 59 regorafenib 59 BiTE 59 brivaracetam 59 Sutent sunitinib 59 Dacogen injection 59 GAMMAGARD 59 Huntingtons disease 59 phase IIa clinical 59 Raptiva ® 59 Daclizumab 59 Onconase 59 LHON 59 volociximab 59 C1 INH 59 refractory gout 59 Panzem 59 LAF# 59 Gattex 59 tolvaptan 59 GW# [003] 59 prucalopride 59 clobazam 59 MELAS 59 baminercept 59 guanfacine extended release 58 Xanafide 58 IBS C 58 bexarotene 58 EndoTAG TM -1 58 HeFH 58 selective modulator 58 Valdoxan 58 Arranon 58 Leber Hereditary Optic Neuropathy 58 Major Depressive Disorder MDD 58 TTR amyloidosis 58 tramiprosate 58 leukemia AML 58 trospium 58 metastatic renal cell carcinoma 58 6R BH4 58 RRMS patients 58 MYDICAR ® 58 JAK inhibitors 58 safinamide 58 Pivotal Phase III 58 PAOD 58 teduglutide 58 teriflunomide 58 Corlux 58 anti CD3 antibody 58 systemic lupus erythematosus SLE 58 biliary tract cancer 58 pharmacological chaperone 58 GALNS 58 interferon beta 1b 58 oral FTY# 58 BAY #-# 58 Androxal TM 58 bortezomib Velcade 58 receptor tyrosine kinase inhibitor 58 Fabry Disease 58 ACZ# 58 neuroprotective effects 58 presymptomatic 58 BMS # 58 daclizumab 58 RoACTEMRA 58 ularitide 58 glatiramer 58 lanthanum carbonate 58 NXL# 58 RLAI 58 Rotigotine 58 Vidaza azacitidine 58 HuMax EGFr 58 relapsing remitting MS RRMS 58 CINOD 58 paroxysmal nocturnal hemoglobinuria PNH 58 Cimzia ® 58 Cimzia ® certolizumab pegol 58 phase IIb trial 58 IL# PE#QQR 58 agomelatine 58 ATL/TV# 58 opioid induced 58 forodesine 58 novel histone deacetylase 58 Lupuzor 58 fibrotic disease 58 Erlotinib 58 metastatic hormone refractory 58 IPLEX 58 Symadex 58 GLYX 58 PPAR gamma agonists 58 S/GSK# 58 HCV protease inhibitors 58 ranolazine 58 TELINTRA 58 INCB# [001] 58 omacetaxine mepesuccinate 58 Serdolect 58 Nuedexta 58 intravenous cyclophosphamide 58 ibudilast 58 pomalidomide 58 SGS# 58 INCB# [002] 58 TNF inhibitor 58 AZILECT R 58 canakinumab 58 angiogenesis inhibitor 58 FTY# 58 Evoltra 58 Sycrest 58 Ocrelizumab 58 inhaled iloprost 58 davunetide intranasal AL 58 pegylated interferons 58 silodosin 58 FOLOTYN ® 58 recurrent glioblastoma 58 Ceflatonin 57 ceftazidime 57 ARIKACE ™ 57 relapsed MM 57 Virulizin ® 57 non metastatic osteosarcoma 57 Dimebon 57 Rebif ® 57 Diamyd ® 57 imatinib resistant 57 heterozygous FH 57 anti amnesic 57 efaproxiral 57 oxypurinol 57 Phase Ib study 57 tipifarnib 57 aclidinium bromide 57 chronic lymphocytic leukemia CLL 57 Cleviprex TM clevidipine 57 Abilify aripiprazole 57 IFN beta 57 Zavesca 57 Denufosol 57 phase IIa 57 Eli Lilly Cymbalta 57 calcineurin inhibitors 57 Bronchitol 57 ulimorelin 57 Sapacitabine 57 Onrigin 57 Torisel 57 Rasagiline 57 RNAi therapeutic targeting 57 CYT# potent vascular disrupting 57 lorvotuzumab mertansine 57 tubulin inhibitor 57 midstage clinical 57 placebo controlled clinical 57 Pyridorin 57 Bosentan 57 Rituxan rituximab 57 Phase IIa clinical 57 P#X# antagonist 57 dirucotide MBP# 57 TEMODAL 57 transgenic mouse models 57 metastatic RCC 57 Aflibercept 57 T2DM 57 TYSABRI natalizumab 57 Fibrillex TM 57 chronic myeloid 57 miglustat 57 Quinamed 57 conventional DMARDs 57 divalproex sodium 57 bendamustine 57 XENAZINE 57 anti arrhythmic drug 57 sodium glucose cotransporter 57 efalizumab 57 vaso occlusive crisis 57 Epratuzumab 57 omecamtiv mecarbil 57 RAPTIVA 57 Telintra 57 Benlysta belimumab 57 fostamatinib 57 sunitinib malate 57 ropinirole Requip 57 Decitabine 57 EOquin 57 Galantamine 57 R#/MEM 57 idiopathic Parkinson disease 57 desvenlafaxine 57 refractory APL 57 diabetic neuropathic pain 57 interferon IFN 57 nalbuphine ER 57 PSN# [002] 57 ORENCIA R 57 neuronal dysfunction 57 Aviptadil 57 ENMD # 57 BRIM3 57 demyelinating 57 RezularTM 57 CINTREDEKIN BESUDOTOX 57 Tolvaptan 57 erlotinib Tarceva 57 octreotide 57 bosentan 57 Fibrillex 57 fibromyalgia syndrome 57 Irinotecan 57 SAR# [004] 57 treat chorea 57 mineralocorticoid receptor 57 Dalbavancin 57 inhaled AAT 57 dexpramipexole 57 INS# [001] 57 ADAGIO study 57 anticancer agent 57 CYT# QbG# 57 Fludarabine 57 remission induction 57 PEG PAL 57 Northera 57 clomipramine 57 PKC# 57 aurora kinase 57 mTOR inhibitor 57 atypical hemolytic uremic syndrome 57 uric acid lowering 57 Paxil paroxetine 57 diabetic gastroparesis 57 Iloperidone 57 RhuDex ® 57 CTEPH 57 INCB# [003] 57 treprostinil 57 PDE4 inhibitor 57 Carbamazepine 57 phase IIb clinical 57 NMDA receptor antagonist 57 COPREXA 57 Zerenex 57 Insegia 57 thetreatment 57 Fingolimod 57 DFMO 57 MAGE A3 ASCI 57 imatinib mesylate 57 levodopa induced dyskinesia 57 chronic idiopathic thrombocytopenic purpura 57 mGluRs 57 histone deacetylase HDAC inhibitor 57 Aryplase 57 Posiphen 57 Orazol 57 TriRima 57 antidepressant efficacy 57 Nexavar tablets 57 tanespimycin 57 postoperative ileus 57 COPAXONE R 57 Herceptin trastuzumab 57 IFN α 57 symptomatic paroxysmal AF 57 diabetic nephropathy 57 disease modifying 57 evaluating tivozanib 56 Cimzia TM 56 dasatinib Sprycel 56 SERCA2a 56 ELACYT 56 nonalcoholic steatohepatitis NASH 56 Cetrorelix 56 iniparib 56 vascular disrupting agent 56 Benign Prostatic Hyperplasia 56 relapsing multiple sclerosis 56 abiraterone 56 BRAF inhibitor 56 goserelin 56 Kuvan 56 Alvesco R 56 myeloproliferative diseases 56 prokinetic agent 56 GHRH 56 tezampanel 56 Avanafil 56 LY# [003] 56 fenretinide 56 senicapoc 56 talabostat 56 bardoxolone methyl 56 Azilect ® 56 AZILECT ® 56 vandetanib 56 gamma secretase inhibitor 56 defibrotide 56 Azacitidine 56 Neulasta ® 56 zileuton 56 nucleoside analog 56 eprotirome 56 Vimpat R 56 HQK 56 INVEGA ® 56 rasagiline tablets 56 relapsed leukemia 56 CAPHOSOL 56 PRT# 56 Vaprisol 56 retinal vein occlusion 56 DDP# 56 Troxatyl 56 somatostatin analogue 56 Neurodex 56 EGFR inhibitors 56 Phase Ib clinical 56 tramiprosate Alzhemed TM 56 Bicifadine 56 R roscovitine 56 paricalcitol 56 darapladib 56 PXD# 56 pulmonary arterial hypertension PAH 56 MYLOTARG 56 Ceflatonin R 56 Enzastaurin 56 aripiprazole Abilify 56 Exelixis XL# 56 interferon beta 56 antiarrhythmic 56 JAK2 inhibitor 56 post operative ileus 56 severe gastroparesis 56 trodusquemine 56 Annamycin 56 hormone refractory prostate cancer 56 xanthine oxidase inhibitor 56 inherited neurodegenerative 56 pulmonary arterial hypertension 56 Vandetanib 56 LymphoStat B TM 56 cholinesterase inhibitors 56 IPL# 56 cancer cachexia 56 DU #b 56 hour bronchodilation 56 RhuDex 56 ASA# 56 exocrine pancreatic insufficiency EPI 56 homozygous FH 56 AGILECT R 56 LT NS# 56 long acting bronchodilator 56 oxcarbazepine 56 PI3K/Akt pathway inhibitor 56 antithrombotic 56 biologic therapy 56 pegaptanib 56 choroidal vasculopathy 56 OXi# 56 recurrent glioblastoma multiforme 56 Rheumatoid Arthritis RA 56 DMARD 56 selective agonist 56 SYN# 56 constipation predominant irritable bowel 56 lenalidomide dexamethasone 56 antidiabetic 56 natriuretic peptide 56 ATACAND 56 antihypertensive therapy 56 gastrointestinal stromal tumors 56 cortical stimulation 56 uricase 56 MNTX 56 demonstrated antitumor activity 56 non alcoholic steatohepatitis 56 carbidopa levodopa 56 R#/MEM # 56 olanzapine LAI 56 GRN# 56 AKT inhibitor 56 Dacogen decitabine 56 cangrelor 56 adecatumumab 56 VAPRISOL 56 idarubicin 56 opioid induced constipation 56 Lixivaptan 56 tolevamer 56 Panzem R 56 Tyrima 56 Candesartan 56 antiarrhythmic drug 56 vismodegib 56 Xerecept 56 levodopa therapy 56 entinostat 56 ruboxistaurin 56 bronchodilatory 56 secondary hyperparathyroidism 56 TBC# 56 receptor inhibitor 56 torezolid phosphate 56 liposomal formulation 56 Silodosin 56 XmAb# 56 ataluren 56 acute HAE attacks 56 Octreotide 56 Oglemilast 56 Guanilib 56 azacitidine 56 pan HDAC inhibitor 56 Tiotropium 56 refractory chronic lymphocytic 56 Parkinson Disease PD 56 velafermin 56 ThGRF 56 pancreatic neuroendocrine tumors 56 IMA# 56 CHOP chemotherapy 56 LymphoStat B belimumab 56 Factor VIIa 56 benign prostatic hypertrophy BPH 56 icatibant 56 Atiprimod 56 KNS # 56 ZACTIMA 56 Serdaxin 56 PDE# inhibitors 56 thalidomide Thalomid 56 Gaboxadol 56 DEB# 56 linaclotide 56 sorafenib tablets 56 Laquinimod 56 neovascular 56 tyrosine kinase inhibitor TKI 56 PHX# 56 gemcitabine Gemzar ® 56 hereditary deficiency 56 ZOLINZA 56 Nexavar ® 56 anti EGFR antibody 56 sorafenib Nexavar 56 LEP ETU 56 Motesanib 56 Teriflunomide 56 lanreotide 56 lysosomal storage diseases 56 Elagolix 56 Ropinirole 56 rilpivirine 56 Phenserine 56 antiplatelet agent 56 Major Depressive Disorder 56 erlotinib Tarceva ® 56 Avicena 56 mRCC 56 #ME# 56 TREANDA 56 cardiac toxicity 56 oral prodrug 56 mTOR inhibitors 56 Pfizer Sutent 56 anthracycline chemotherapy 56 TNF alpha inhibitor 55 diabetic kidney 55 systemic lupus erythematosus 55 IL 1ß 55 Cethromycin 55 anti angiogenic agents 55 ULORIC 55 radezolid 55 NYHA Class II 55 SSRI antidepressant 55 pulmonary hypertension PH 55 Darusentan 55 pancreatic insufficiency 55 aHUS 55 chemotherapy induced neutropenia 55 familial hypercholesterolemia FH 55 peritumoral brain edema 55 PDE4 inhibitors 55 Prestara 55 ACTEMRA TM 55 ONTAK 55 velaglucerase alfa 55 tyrosine kinase inhibitor 55 Fampridine 55 Glatiramer acetate 55 XL# SAR# 55 Ramelteon 55 ALN TTR# 55 pagoclone 55 myelofibrosis 55 Evoltra ® 55 galantamine 55 CRLX# 55 Phase IIa trials 55 relapsed refractory multiple myeloma 55 asenapine 55 Bezielle 55 potentially hepatotoxic 55 Parkinson disease epilepsy 55 JP-#/fipamezole 55 neuroprotective properties 55 hypercalcemia 55 Certolizumab pegol 55 chronic myeloid leukemia CML 55 PRTX 55 hematologic disorders 55 Noxafil 55 idiopathic thrombocytopenic purpura 55 ALK inhibitor 55 adalimumab Humira 55 alagebrium 55 rotigotine transdermal patch 55 proliferative diabetic retinopathy 55 LY# [002] 55 tasocitinib 55 redox active 55 sunitinib 55 intranasal formulation 55 Gefitinib 55 CIPN 55 atypical neuroleptics 55 galiximab 55 romiplostim 55 anticancer compound 55 PEG SN# 55 Cycloset 55 relapsing forms 55 apremilast 55 hypereosinophilic syndrome 55 DPP4 inhibitor 55 metastatic malignant 55 OX1 55 Proxinium TM 55 rhIGF-I/rhIGFBP-3 55 SHPT 55 nitric oxide donating prostaglandin 55 huC# DM4 55 Actelion Tracleer 55 selegiline 55 ORENCIA ® 55 ximelagatran 55 Hedgehog Pathway Inhibitor 55 NMDA receptor antagonists 55 romidepsin 55 sargramostim 55 Alzheimer disease AD 55 VEGF Trap 55 pouchitis 55 renal anemia 55 memantine 55 Bifeprunox 55 dopaminergic therapy 55 glufosfamide 55 IGIV 55 dose cohort 55 Topiramate 55 Capecitabine 55 homozygous familial hypercholesterolemia 55 pseudobulbar affect PBA 55 midstage trials 55 ixabepilone 55 Azedra 55 Phase 1a clinical 55 monotherapy 55 favorable pharmacokinetic profile 55 dirucotide 55 Zavesca R 55 neurological manifestations 55 Firdapse 55 Alemtuzumab 55 PrevOnco 55 tegaserod 55 URG# 55 relapsed ovarian cancer 55 adipiplon 55 cardiac repolarization 55 ON #.Na 55 A1PI 55 erythropoietic 55 Ramoplanin 55 PsA 55 octreotide implant 55 stage IIIB 55 tigecycline 55 anti angiogenic therapy 55 esophageal candidiasis 55 refractory acute myeloid 55 Retigabine 55 EGFR HER2 55 Hematologic 55 GSK# [002] 55 Bronchiectasis 55 Myelodysplastic Syndrome MDS 55 Kevetrin 55 LHRH agonists 55 VIDAZA 55 fluticasone furoate 55 BAL# [002] 55 thrombocytopenic patients 55 Squalamine 55 aflibercept 55 Oral NKTR 55 BEMA TM Fentanyl 55 TORISEL 55 Phase 2a trial 55 Pivotal Phase 55 decitabine 55 opioid induced bowel dysfunction 55 Icatibant 55 preclinical efficacy 55 relapsed multiple myeloma 55 trastuzumab DM1 55 Phase IIIb clinical 55 tiotropium 55 systemic juvenile idiopathic 55 Ilaris 55 BrachySil TM 55 Hypercholesterolemia 55 FLT3 55 candesartan cilexetil 55 ELND# 55 amphotericin B 55 docetaxel Taxotere ® 55 Randomized Phase 55 dyskinesia PD LID 55 REMICADE infliximab 55 ara C 55 RG# [001] 55 entacapone 55 Phase 2a 55 alemtuzumab 55 Kepivance 55 AEGR 55 Aplidin R 55 briakinumab 55 mapatumumab 55 adalimumab 55 milnacipran 55 sertraline Zoloft 55 PEGylated interferon 55 Toxicities 55 hypomethylating agents 55 EVIZON 55 ALB # 55 MEK inhibitors 55 Evoltra TM 55 phosphate binder 55 Thiarabine 55 Cimzia certolizumab pegol 55 Asentar 55 relapsed SCLC 55 Serdolect ® 55 Olanzapine 55 PBT2 55 reslizumab 55 metastatic gastric 55 Zolinza 55 pain palliation 55 QLT# 55 Interferon beta 55 denufosol 55 tumor necrosis 55 pyridostigmine 55 TACI Ig 55 BLA filing 55 XL# [003] 55 TG# [003] 55 subependymal giant cell 55 AAT deficiency 55 noninfectious uveitis 55 Vimpat lacosamide 55 orally bioavailable 55 Lenalidomide 55 standard chemotherapy regimen 55 Hsp# Inhibitor 55 CD# CEA 55 chlorambucil 55 Nilotinib 55 chronic thromboembolic pulmonary 55 Prodarsan ® 55 Vitaxin 55 Phase 2a clinical 55 ® natalizumab 55 dopamine agonist 55 histone deacetylase inhibitor 55 gepirone ER 55 Bapineuzumab 55 OMNARIS Nasal Spray 55 lurasidone 55 RNAi therapeutic targeting PCSK9 55 pitavastatin 55 Viprinex 55 MAP# 55 herpetic keratitis 55 BZL# 55 Lubiprostone 55 CA4P 55 pharmacokinetic interactions 55 cardiotoxic 55 pulmonary exacerbations 55 MabThera rituximab 55 Syncria 55 Linaclotide 55 T1DM 55 ONCONASE R 55 opioid bowel dysfunction 55 LHRH antagonists 55 lixivaptan 55 epothilone 55 denileukin diftitox 55 Cancidas 55 PDGF receptor 55 AVONEX ® 55 systemic fungal infections 55 otelixizumab 55 Omacetaxine 55 receptor antagonists 55 carcinoid tumors 55 Intervention Effectiveness 55 Morquio 55 ECTRIMS 55 acute mania 55 REMICADE ® 55 Promacta 55 mGluR5 antagonists 55 alvimopan 55 Hemophilia B 55 cutaneous T cell 55 Orally administered 55 Gemzar ® 55 Dyloject TM 55 Velcade bortezomib 55 systemically administered 55 trabectedin 55 Etanercept 55 Myelofibrosis 55 TNF antagonist 55 Rebif interferon beta 1a 54 dihydrochloride 54 Carbidopa 54 Zavesca ® 54 ziconotide 54 alkylating agent 54 PF # [001] 54 MGd 54 Vorinostat 54 TRISENOX 54 CIMZIA TM 54 MGCD# [001] 54 fingolimod 54 CEQ# 54 myeloproliferative disorders 54 incyclinide 54 bipolar depression 54 Factor Xa inhibitor 54 CB1 antagonists 54 cancer neuroendocrine tumor 54 Ventavis 54 Shigamabs ® 54 pertuzumab 54 hepatic encephalopathy 54 AA amyloidosis 54 investigational drug 54 IMP# 54 Panzem R NCD 54 Viramidine 54 Onbrez Breezhaler 54 DR Cysteamine 54 FVIIa 54 mGlu2 3 54 beta secretase inhibitors 54 relapsed ALL 54 Mitoxantrone 54 HuMax CD# 54 Phase 2b trial 54 cilengitide 54 neurotrophic factor 54 eniluracil 54 MYDICAR 54 Relivar 54 lucinactant 54 UCB Cimzia 54 VPRIV 54 Adentri 54 investigational therapies 54 HGS# 54 levodopa carbidopa 54 beta interferons 54 ICA # 54 frovatriptan 54 vinorelbine tartrate 54 Phase IIa trial 54 NUVIGIL 54 mGluR2 54 nabilone 54 Golimumab 54 ospemifene 54 cachexia 54 oral rivaroxaban 54 mycophenolate mofetil 54 Sudhir Agrawal D.Phil 54 chronic ITP patients 54 Parkinson disease PD 54 post herpetic neuralgia PHN 54 phase IIb 54 NAGS deficiency 54 OMNARIS HFA 54 bleomycin 54 Hedgehog antagonist 54 metastatic neuroendocrine tumors 54 ALD# 54 Zenvia Phase III 54 Enkephalin 54 complement inhibitor eculizumab 54 PSN# [001] 54 Phase Ib II 54 QVA# 54 ponatinib 54 mipomersen 54 Almorexant 54 OncoVEX GM CSF 54 angiotensin receptor blocker ARB 54 Trandolapril 54 Uricase PEG 54 Lacosamide 54 SU# [003] 54 Tocosol Paclitaxel 54 neuroleptic 54 topically administered 54 intravenous AAT 54 RH1 54 ACTEMRA 54 gemcitabine carboplatin 54 Virulizin R 54 L dopa 54 Tavocept 54 nociceptive pain 54 Emselex 54 iloprost 54 squalamine 54 docetaxel chemotherapy 54 Navelbine ® 54 TYKERB 54 Rescula 54 Leukine 54 DITPA 54 Tardive Dyskinesia 54 PROCHYMAL 54 progressive neurodegenerative 54 hepatotoxicity 54 bapineuzumab 54 either acutely decompensated